#53905
Re: Farmas USA
uso bno
ojo petroleo reunión importante, podemos estar en mínimos.
Se está hablando de:
#53906
Re: Farmas USA
Reunión mañana 27, coincidiendo con el Día de Acción de Gracias (thanksgiving) y con el mercado USA cerrado.
Si alguién quiere hacer algo deberá esperar al viernes, pero como tienen que digerir bien el pavo, solo abierto hasta las 19h.
#53907
Re: Farmas USA
Hola David...
Un offering de esta noche....
Ahora quizás sí que vamos a ver tu precio...
http://ih.advfn.com/p.php?pid=nmona&article=64561691&xref=newsalert
ISCO
#53908
Re: Farmas USA
ONCS
http://finance.yahoo.com/news/oncs-results-newly-initiated-phase-140000517.html
Initiation of a landmark Phase II combination trial in collaboration with the UCSF and Merck to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 drug, KEYTRUDA® (pembrolizumab) in combination with OncoSec’s ImmunoPulse therapy (intratumoral IL- 12) for the treatment of metastatic melanoma patients, who are non-responsive to KEYTRUDA®
No puede pintar mejor. Precio objetivo sube de 2$ a 4$
¿alguien que aún las mantenga como yo?
#53909
Re: Farmas USA
hombre Sabiopelotas! que caro eres de ver!
:)
#53910
Re: Farmas USA
BASF sells Norway Plant
BASF es uno de los 4 suministradores de pastis Vascepa
AMRN
#53911
Re: Farmas USA
SNTA
muy corto plazo, necesitamos un "tercer toque" para confirmar
La MM20 a puntito de cruzarse desde abajo con la MM50
#53912
Re: Farmas USA
Analyst Update on Short Term Price Target:Walgreen Company , Novavax Inc
Novavax Inc (NASDAQ:NVAX) shares are expected to touch $9.5 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 1.41. The target price could hit $11 on the higher end and $7 on the lower end. Novavax Inc (NASDAQ:NVAX) : Optimism-led buying helped Novavax Inc (NASDAQ:NVAX)post gains of 0.19% or 0.01 points. The mood remained fairly bullish throughout the day and no significant downmove or selling pressure was witnessed. During the day, the shares fluctuated in $5.17-$5.29 but finally closed higher at $5.26. The shares had closed the previous day trading session at $5.25. The 52-week high of Novavax Inc (NASDAQ:NVAX) is at $6.95. The volume for the day was recorded at 1,984,445 shares. Currently, there are 238,478,000 outstanding shares and the company has a market cap of $1,254 million. The 52-week low of the shares is at $3.33.
Me hace gracia lo del "short-term" ... que relativo es ja,ja
NVAX
edito: añado un grafico en MENSUAL de como vamos
esos 5,60 ... que cerca y que lejillos estan ahora ...
